IDEAS home Printed from https://ideas.repec.org/a/etc/journl/y2023i28p29-58.html
   My bibliography  Save this article

Simile on sense of self, virocell and the COVID19 pandemic

Author

Listed:
  • Chidinma Iheanetu
  • Viola Tamášová
  • Roman Tandlich

Abstract

The virocell concept of a viral lifecycle maintains that there are two main stages in a virus’s existence. The one is a passive state of a virion, which is not a living entity, and the second one is the virocell. In the state of virocell, a virus infects a host’s cell and hijacks its cellular machinery to achieve its own replication. Depending on the way that a cell reacts to a viral infection, it can have its activities or character as an individual living organism, suppressed completely, to some extent or not at all. In the article, the authors propose that there is analogy between the virocell theory as applied to the SARS-CoV-2 virus lifecycle and the sense of self for humans in the coronavirus pandemic world, and the post-COVID19 space-time. Methodology adopted is a combination of simile of Wittgenstein’s parallel cases, autoethnography, the virocell concept of the SARV-CoV-2 lifecycle and a multi-individual nature of one’s self based on the principles of the assemblage theory. The nature of human existence and the sense of self is defined as a relational notion which is tied to the societal educational standards, phases of developments of a human being and their fluid sense of self. The COVID19 pandemic space-time provides, in fact it demands that humanity undergoes an ongoing education of itself to maintain a productive and resilient movement forward for self and society, as an equivalent of the ribovirocell of a human cell infected with the coronavirus. The notion of speed will have to be unpacked and investigated further, which is done in part in a follow up article and is anchored as the defining characteristics of the post-COVID19 world.

Suggested Citation

  • Chidinma Iheanetu & Viola Tamášová & Roman Tandlich, 2023. "Simile on sense of self, virocell and the COVID19 pandemic," Academicus International Scientific Journal, Entrepreneurship Training Center Albania, issue 28, pages 29-58, July.
  • Handle: RePEc:etc:journl:y:2023:i:28:p:29-58
    as

    Download full text from publisher

    File URL: https://academicus.edu.al/nr28/Academicus-MMXXIII-28-029-058.pdf
    Download Restriction: no

    File URL: https://academicus.edu.al/nr28/Academicus-MMXXIII-28-029-058.html
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Houriiyah Tegally & Eduan Wilkinson & Marta Giovanetti & Arash Iranzadeh & Vagner Fonseca & Jennifer Giandhari & Deelan Doolabh & Sureshnee Pillay & Emmanuel James San & Nokukhanya Msomi & Koleka Mlis, 2021. "Detection of a SARS-CoV-2 variant of concern in South Africa," Nature, Nature, vol. 592(7854), pages 438-443, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Chidinma Uche Iheanetu & Viola Tamášová & Roman Tandlich, 2024. "Speed, human reality, and the ribovirocell of human existence in the COVID19 and post-COVID19 space-time," Academicus International Scientific Journal, Entrepreneurship Training Center Albania, issue 29, pages 38-61, January.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Li Wang & Markus H. Kainulainen & Nannan Jiang & Han Di & Gaston Bonenfant & Lisa Mills & Michael Currier & Punya Shrivastava-Ranjan & Brenda M. Calderon & Mili Sheth & Brian R. Mann & Jaber Hossain &, 2022. "Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    2. X. Tong & R. P. McNamara & M. J. Avendaño & E. F. Serrano & T. García-Salum & C. Pardo-Roa & H. L. Bertera & T. M. Chicz & J. Levican & E. Poblete & E. Salinas & A. Muñoz & A. Riquelme & G. Alter & R., 2023. "Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    3. Beatrice Casati & Joseph Peter Verdi & Alexander Hempelmann & Maximilian Kittel & Andrea Gutierrez Klaebisch & Bianca Meister & Sybille Welker & Sonal Asthana & Salvatore Giorgio & Pavle Boskovic & Ka, 2022. "Rapid, adaptable and sensitive Cas13-based COVID-19 diagnostics using ADESSO," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    4. Elizabeth M. Parzych & Jianqiu Du & Ali R. Ali & Katherine Schultheis & Drew Frase & Trevor R. F. Smith & Jiayan Cui & Neethu Chokkalingam & Nicholas J. Tursi & Viviane M. Andrade & Bryce M. Warner & , 2022. "DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    5. Meriem Bekliz & Kenneth Adea & Pauline Vetter & Christiane S. Eberhardt & Krisztina Hosszu-Fellous & Diem-Lan Vu & Olha Puhach & Manel Essaidi-Laziosi & Sophie Waldvogel-Abramowski & Caroline Stephan , 2022. "Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    6. Kuan-Ying A. Huang & Xiaorui Chen & Arpita Mohapatra & Hong Thuy Vy Nguyen & Lisa Schimanski & Tiong Kit Tan & Pramila Rijal & Susan K. Vester & Rory A. Hills & Mark Howarth & Jennifer R. Keeffe & Ale, 2023. "Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    7. Oliver Eales & Leonardo Oliveira Martins & Andrew J. Page & Haowei Wang & Barbara Bodinier & David Tang & David Haw & Jakob Jonnerby & Christina Atchison & Deborah Ashby & Wendy Barclay & Graham Taylo, 2022. "Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    8. Yanqun Wang & An Yan & Deyong Song & Maoqin Duan & Chuangchuang Dong & Jiantao Chen & Zihe Jiang & Yuanzhu Gao & Muding Rao & Jianxia Feng & Zhaoyong Zhang & Ruxi Qi & Xiaomin Ma & Hong Liu & Beibei Y, 2024. "Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    9. Vincent Pavot & Catherine Berry & Michael Kishko & Natalie G. Anosova & Lu Li & Tim Tibbitts & Dean Huang & Alice Raillard & Sylviane Gautheron & Cindy Gutzeit & Marguerite Koutsoukos & Roman M. Chicz, 2023. "Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates," Nature Communications, Nature, vol. 14(1), pages 1-8, December.
    10. Jörg Paetzold & Janine Kimpel & Katie Bates & Michael Hummer & Florian Krammer & Dorothee Laer & Hannes Winner, 2022. "Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot," Nature Communications, Nature, vol. 13(1), pages 1-7, December.
    11. Peter Radvak & Hyung-Joon Kwon & Martina Kosikova & Uriel Ortega-Rodriguez & Ruoxuan Xiang & Je-Nie Phue & Rong-Fong Shen & James Rozzelle & Neeraj Kapoor & Taylor Rabara & Jeff Fairman & Hang Xie, 2021. "SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    12. Cassia Wagner & Kathryn E. Kistler & Garrett A. Perchetti & Noah Baker & Lauren A. Frisbie & Laura Marcela Torres & Frank Aragona & Cory Yun & Marlin Figgins & Alexander L. Greninger & Alex Cox & Hann, 2024. "Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    13. Vincent Pavot & Catherine Berry & Michael Kishko & Natalie G. Anosova & Dean Huang & Tim Tibbitts & Alice Raillard & Sylviane Gautheron & Cindy Gutzeit & Marguerite Koutsoukos & Roman M. Chicz & Valer, 2022. "Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates," Nature Communications, Nature, vol. 13(1), pages 1-9, December.
    14. Krishna P. Reddy & Kieran P. Fitzmaurice & Justine A. Scott & Guy Harling & Richard J. Lessells & Christopher Panella & Fatma M. Shebl & Kenneth A. Freedberg & Mark J. Siedner, 2021. "Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa," Nature Communications, Nature, vol. 12(1), pages 1-10, December.
    15. Mark P. Khurana & Jacob Curran-Sebastian & Neil Scheidwasser & Christian Morgenstern & Morten Rasmussen & Jannik Fonager & Marc Stegger & Man-Hung Eric Tang & Jonas L. Juul & Leandro Andrés Escobar-He, 2024. "High-resolution epidemiological landscape from ~290,000 SARS-CoV-2 genomes from Denmark," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    16. Ma’ayan Israeli & Yaara Finkel & Yfat Yahalom-Ronen & Nir Paran & Theodor Chitlaru & Ofir Israeli & Inbar Cohen-Gihon & Moshe Aftalion & Reut Falach & Shahar Rotem & Uri Elia & Ital Nemet & Limor Klik, 2022. "Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    17. Yifan Wang & Caixuan Liu & Chao Zhang & Yanxing Wang & Qin Hong & Shiqi Xu & Zuyang Li & Yong Yang & Zhong Huang & Yao Cong, 2022. "Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    18. Claudia Del Vecchio & Bethan Cracknell Daniels & Giuseppina Brancaccio & Alessandra Rosalba Brazzale & Enrico Lavezzo & Constanze Ciavarella & Francesco Onelia & Elisa Franchin & Laura Manuto & Federi, 2022. "Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    19. Gabriela Lobinska & Ady Pauzner & Arne Traulsen & Yitzhak Pilpel & Martin A. Nowak, 2022. "Evolution of resistance to COVID-19 vaccination with dynamic social distancing," Nature Human Behaviour, Nature, vol. 6(2), pages 193-206, February.
    20. Lei Peng & Yingxia Hu & Madeleine C. Mankowski & Ping Ren & Rita E. Chen & Jin Wei & Min Zhao & Tongqing Li & Therese Tripler & Lupeng Ye & Ryan D. Chow & Zhenhao Fang & Chunxiang Wu & Matthew B. Dong, 2022. "Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617," Nature Communications, Nature, vol. 13(1), pages 1-18, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:etc:journl:y:2023:i:28:p:29-58. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Gabor Vasmatics (email available below). General contact details of provider: https://edirc.repec.org/data/etctial.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.